This site is intended for healthcare professionals only
LoginRegister
NPPA Sets New Retail Price for Cilnidipine, Telmisartan CombinationNPPA Fixes Ceiling Price of Ringer Lactate Injection
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialNovartis receives USFDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA...
Martin A. Makary sworn in as FDA CommissionerMartin A. Makary sworn in as FDA Commissioner
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases
GPAT 2025 Registration Begins.GPAT 2025 Registration Begins! Check out application process, eligibility criteria, exam scheme, all...
Sanofi to expand respiratory vaccines pipeline with acquisition of VicebioLupin UK arm acquires Renascience Pharma for over Rs 138 crore
Bajaj Healthcare CFO Dayashankar Patel resignsBajaj Healthcare CFO Dayashankar Patel resigns
Allegation of medical negligence at Balurghat HospitalGland Pharma receives USFDA nod for pain management injection Acetaminophen
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJnJ closes Intra-Cellular Therapies acquisition
Bayer Nubeqa gets EU approvalBayer Pharmaceutical Gets CDSCO Panel Nod To Import And Market Octocog alfa for hemophilia A
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialCDSCO Panel Approves Novartis Protocol Amendment Proposal fo Ianalumab study
Mass layoffs begin at FDA, CDC, other US health agenciesMass layoffs begin at FDA, CDC, other US health agencies
X